Andrew Jacobs

Veterans under 30 will have to sign forms before being given antidepressants. Medical groups fear the moves may stigmatize mental health treatment.

Scientists are developing imaging techniques and blood tests that one day may enable doctors to identify the disease definitively in living patients.

The preliminary research was conducted in mice, but scientists were optimistic the results would apply to humans. Clinical trials begin this month.

For decades, conservatives were adamantly opposed to the use of drugs like psilocybin and LSD. Now, the Trump administration has made a sharp pivot.

An upcoming executive order is intended to accelerate research into the compounds’ efficacy in treating PTSD, depression and other mental health problems.

An analysis of hundreds of images from several studies shows how hallucinogenic drugs drive activity in various regions of the brain.

The country’s experiment with psychedelic medicine has led to positive outcomes, psychiatrists say, but also highlights the limitations of the nascent field.

The A.M.A.’s announcement followed a similar recommendation from the American Society of Plastic Surgeons. Other medical groups argued for a more personalized approach.

In a legal first, a jury in New York awarded $2 million to a patient who said that doctors had deviated from accepted medical standards.

The organization’s latest guidance is a departure from the prevailing views of several other major medical organizations.